Company records / elypta.com
Elypta
Elypta (elypta.com): 5 changes recorded in its website history since March 2018. Homepage last checked 5 November 2026.
Recorded changes
- MessagingBetween and
Advancing Cancer Detection
Early detection of cancer starts with knowing who's at risk
- ComplianceBetween and
Now states ISO 13485 compliance on its homepage.
- HeadlineBetween and
We measure the GAGome — system biomarkers of tumor metabolism — then use machine learning to detect signatures of cancer noninvasively
Advancing Cancer Detection
- HeadlineBetween and
Why a liquid biopsy based on metabolism?
We measure the GAGome — system biomarkers of tumor metabolism — then use machine learning to detect signatures of cancer noninvasively
- HeadlineBetween and
Why a system biomarker for cancer?
Why a liquid biopsy based on metabolism?
First recorded website
Observed 7 March 2018
How it described itself
Why a system biomarker for cancer?
Our mission is to prevent cancer mortality through earlier detection and closer monitoring of disease.
How it describes itself
Early detection of cancer starts with knowing who's at risk
Inspect 8 captures in this group
- ·
Advancing Cancer Detection
archived page - ·
Advancing Cancer Detection
archived page - ·
Advancing Cancer Detection
archived page - ·
Advancing Cancer Detection
archived page - ·
Advancing Cancer Detection
archived page - ·
Advancing Cancer Detection
archived page - ·
Advancing Cancer Detection
archived page - ·
Early detection of cancer starts with knowing who's at risk
current website
- ·
We measure the GAGome — system biomarkers of tumor metabolism — then use machine learning to detect signatures of cancer noninvasively
Why a liquid biopsy based on metabolism?
Inspect 2 captures in this group
- ·
Why a liquid biopsy based on metabolism?
archived page - ·
Why a liquid biopsy based on metabolism?
archived page
- ·
Why a system biomarker for cancer?
Cite this record
StartupHistory, “Elypta” company record, https://startuphistory.org/c/elypta.com